Evidence-based assessment of treatment options for children with IgA nephropathies.
about
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)Immunosuppressive agents for treating IgA nephropathyInterventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)Immunosuppressive agents for treating IgA nephropathyIndications for tonsillectomy stratified by the level of evidenceIdiopathic immunoglobulin A nephropathy in children and adolescents.Long-term results of a randomized controlled trial in childhood IgA nephropathy.Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.Management of leukocytoclastic vasculitis.Improved renal survival in Japanese children with IgA nephropathyAdjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic reviewTreatment Outcomes in Children with Henoch-Schönlein Nephritis.Clinical remission of Henoch-Schönlein purpura nephritis after a monotherapeutic tonsillectomy.Managing Henoch-Schonlein purpura in children with fish oil and ACE inhibitor therapy.Unusual presentation of IgA nephropathy in childhood: a case report.Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment.Long-term follow up of pediatric immunoglobulin A nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.Plasma oxidative stress level of IgA nephropathy in children and the effect of early intervention with angiotensin-converting enzyme inhibitors.
P2860
Q24187962-2144EFE6-98E5-4378-AB95-C68E5444E178Q24188035-87AB2797-A172-4E4E-A72D-131ED265C25BQ24239940-5F3DDFB2-6350-467E-AA5B-39D0AF9496B9Q24247680-6AA395B8-7C86-4330-BFDB-298BB5413494Q28068602-A483B000-60D6-4B36-BC5E-1A28326721B5Q33731499-3A9B8A7B-D995-45F2-9F8B-EF8B7587B3ACQ35030576-3DA0E647-90FD-401D-AD41-DA0B12C4CDD8Q35885198-4D7CA991-BFA8-4FCD-AFFF-526E61C374E4Q36297037-1656B85B-5229-487C-A87F-B0C9B122F08EQ36585452-74EDA9BA-6ADE-4770-B0A2-C570C44B9E2FQ37667314-002BAFF4-8B9C-4887-A1F6-ABCC55AA79A4Q39823865-C578D812-03DE-4E21-8FD6-067CB549B7ECQ39839615-D89DF7E1-6690-4F00-B3F7-B6B1462BC78FQ45233130-7AE42813-148D-41E2-8E1C-8593E3221C86Q46848770-2745E562-F195-4253-96C2-90D98503D4CAQ51680137-14A7E809-BFA2-4FB7-B4F7-F6E13A908678Q51683190-2BF5950F-C253-4DCE-993E-BD4AF23FA882Q53097934-1E30FC36-3157-49F4-953E-6F12B958A3BA
P2860
Evidence-based assessment of treatment options for children with IgA nephropathies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evidence-based assessment of treatment options for children with IgA nephropathies.
@ast
Evidence-based assessment of treatment options for children with IgA nephropathies.
@en
Evidence-based assessment of treatment options for children with IgA nephropathies.
@nl
type
label
Evidence-based assessment of treatment options for children with IgA nephropathies.
@ast
Evidence-based assessment of treatment options for children with IgA nephropathies.
@en
Evidence-based assessment of treatment options for children with IgA nephropathies.
@nl
prefLabel
Evidence-based assessment of treatment options for children with IgA nephropathies.
@ast
Evidence-based assessment of treatment options for children with IgA nephropathies.
@en
Evidence-based assessment of treatment options for children with IgA nephropathies.
@nl
P356
P1433
P1476
Evidence-based assessment of treatment options for children with IgA nephropathies.
@en
P2093
P2888
P304
P356
10.1007/S004670000517
P577
2001-02-01T00:00:00Z
P5875
P6179
1005175760